Clinical Trials Browser

Phase 1 × Advanced Solid Tumors × CTLA-4 Antigen × Clear all

NCT03545971 2023-02-28

A Study of IBI310 for the Treatment of Patients With Advanced Solid Tumors.

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors